ASX Announcements


 
    Appendix 2A - options exercise & cleansing notice  
 
    Change of Director's interest notice x 4  
 
    Appendix 2A - options exercise & cleansing notice  
 
    Appendix 2A  
 
    Appendix 3G  
 
    Issue of securities approved at AGM  
 
    TGA announces final CBD down-scheduling decision  
 
    Results of Annual General Meeting  
 
    Company Update to the AGM  
 
    First Australian Medicinal Cannabis Oils Exported to Germany  
 
    Proposed issue of Securities - LGP  
 
    LGP enters strategic partnership with HIF  
 
    Trading Halt  
 
    Proposed issue of Securities - LGP  
 
    Letter to Shareholders regarding Annual General Meeting  
 
    Notice of Annual General Meeting  
 
    Appendix 2A - Exercise of Options and Cleansing Notice  
 
    Quarterly Activities Report & Appendix 4C  
 
    Becoming a substantial holder- Tiga Trading Pty Ltd  
 
    Little Green Pharma granted GMP Licence  
 
    Appendix 2A - Release from Escrow  
 
    AGM Date and Closing Date for Director Nominations  
 
    Notice of release from escrow  
 
    TGA Medicinal Cannabis Post Market Survey  
 
    LGP welcomes proposed CBD down-scheduling  
 
    Change in substantial holding  
 
    Appendix 4G  
 
    2020_Annual Report to shareholders  
 
    Appendix 2A and Cleansing Notice  
 
    Proposed issue of Securities - LGP  
 
    Appendix 2A and Cleansing Notice  
 
    Appendix 2A - Exercise of Options and Cleansing Notice  
 
    Appendix 2A - Release from Escrow  
 
    Change in substantial holding  
 
    Notice of Release from Escrow  
 
    Investor Update Webinar  
 
    Investor Presentation  
 
    July 2020_Quarterly Activities Report and Appendix 4C  
 
    Medicinal Cannabis Permit Granted for Expanded Facility  
 
    Appendix 2A - Exercise of Options and Cleansing Notice  
 
    Appendix 2A - Release from Escrow  
 
    Notice of Release from Escrow  
 
    Change of Company Secretary  
 
    Strategic Shipment Exported to the UK  
 
    Sales Update - April 2020  
 
    Clarification Statement  
 
    ODC Manufacturing Permit Granted  
 
    Proposed issue of Securities - LGP  
 
    Investor Presentation  
 
    March 2020_Quarterly Activities Report and Appendix 4C  
 
    Virtual Conference  
 
    First UK Shipment of Australian Medicinal Cannabis Oil  
 
    COVID-19 Business Update  
 
    Commissioning of Cultivation Facility Expansion Complete  
 
    Investor Presentation  
 
    Expanded Medicinal Licence and new Manufacturing Licence  
 
    Fourth Medicinal Cannabis Oil Product  
 
    Appendix 4D and Half Yearly Report  
 
    German Purchase Agreement with Demecan  
 
    Becoming a substantial holder - Elixxer Ltd  
 
    Becoming a substantial holder - FS  
 
    Initial Director's Interest Notice - AC  
 
    Initial Director's Interest Notice - FS  
 
    Initial Director's Interest Notice - NF  
 
    Initial Director's Interest Notice - MLB  
 
    Binding Purchase Agreement with UK-Based Astral Health  
 
    Confirmation Statements  
 
    Top 20 Holders  
 
    Distribution Schedule  
 
    Securities Trading Policy  
 
    Corporate Governance Statement  
 
    Employee Incentive Plan Terms  
 
    Updated Pro-Forma Balance Sheet  
 
    Financial Statements - 30 June 2019  
 
    Financial Statements - 30 June 2018  
 
    Constitution  
 
    Supplementary Prospectus  
 
    Prospectus  
 
    Appendix 1A and Information Form and Checklist  
 
    ASX Notice - Admission to Official List